Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-19

Clinical Trial Update: Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms

View source ↗

Summary

This clinical trial investigates whether interleukin-17 (IL-17) acts as an orchestrator between peripheral inflammation and depressive symptoms in individuals w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Psoriatic Arthritis, Depression | Status: RECRUITING